Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD

Neurology

Volumn 82, Issue 16, 2014, Pages 1455-1462

  Carrasquillo, Minerva M ^a   Khan, Qurat Ul Ain ^a   Murray, Melissa E ^a   Krishnan, Siddharth ^a   Aakre, Jeremiah ^a   Pankratz, V Shane ^a   Nguyen, Thuy ^a   Ma, Li ^a   Bisceglio, Gina ^a   Petersen, Ronald C ^a   Younkin, Steven G ^a   Dickson, Dennis W ^a   Boeve, Bradley F ^a   Graff Radford, Neill R ^a   Ertekin Taner, Nilüfer ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CD2 ASSOCIATED PROTEIN; CD33 ANTIGEN; EPHRIN RECEPTOR A1;

ABCA7 GENE; ALZHEIMER DISEASE; ARTICLE; BIN1 GENE; BRAIN CORTEX ATROPHY; CLU GENE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MS4A6A GENE; PICALM GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ATROPHY; BRAIN CORTEX; BRAIN VENTRICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; GENETICS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; SWEDEN; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; CEREBRAL CORTEX; CEREBRAL VENTRICLES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC VARIATION; HUMANS; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; SWEDEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84901855289     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000335     Document Type: Article

References (27)

1. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol 2012; 11: 170-178.
2. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol 1988; 45: 789-793.
3. Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV. Posterior cortical atrophy: neuropathologic correlations. Arch Neurol 1994; 51: 269-274. (Pubitemid 24088413)
4. Ala TA, Frey WH II, Clark HB. Posterior cortical atrophy: neuropathological correlations. Arch Neurol 1996; 53: 958. (Pubitemid 26340028)
5. Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 2004; 63: 1168-1174. (Pubitemid 39350012)
6. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007; 130: 2636-2645. (Pubitemid 47511719)
7. Renner JA, Burns JM, Hou CE, McKeel DW Jr, Storandt M, Morris JC. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 2004; 63: 1175-1180. (Pubitemid 39350013)
8. de Souza LC, Corlier F, Habert MO, et al. Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease. Brain 2011; 134: 2036-2043.
9. Seguin J, Formaglio M, Perret-Liaudet A, et al. CSF biomarkers in posterior cortical atrophy. Neurology 2011; 76: 1782-1788.
10. Rosenbloom MH, Alkalay A, Agarwal N, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 2011; 76: 1789-1796.
11. Lehmann M, Ghosh PM, Madison C, et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 2013; 136: 844-858.
12. Snowden JS, Stopford CL, Julien CL, et al. Cognitive phenotypes in Alzheimer's disease and genetic risk. Cortex 2007; 43: 835-845. (Pubitemid 47520450)
13. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41: 1088-1093.
14. Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41: 1094-1099.
15. Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010; 303: 1832-1840.
16. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33, and CD2AP are associated with Alzheimer's disease. Nat Genet 2011; 43: 429-435.
17. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33, and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011; 43: 436-441.
18. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
19. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7: 180-184. (Pubitemid 24174658)
20. Petersen RC, Waring SC, Smith GE, Tangalos EG, Thibodeau SN. Predictive value of APOE genotyping in incipient Alzheimer's disease. Ann NY Acad Sci 1996; 802: 58-69. (Pubitemid 27055500)
21. Carrasquillo MM, Belbin O, Hunter TA, et al. Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study. Mol Neurodegener 2011; 6: 54.
22. Carrasquillo MM, Belbin O, Hunter TA, et al. Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. J Alzheimers Dis 2011; 24: 751-758.
23. Carrasquillo MM, Belbin O, Hunter TA, et al. Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Arch Neurol 2010; 67: 961-964.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. (Pubitemid 14076461)
25. Nielsen DM, Ehm MG, Weir BS. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 1998; 63: 1531-1540. (Pubitemid 30418550)
26. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007; 39: 17-23. (Pubitemid 46026496)
27. Carrasquillo MM, Zou F, Pankratz VS, et al. Genetic variation in PCDH11X is associated with susceptibility to lateonset Alzheimer's disease. Nat Genet 2009; 41: 192-198.